0001144204-16-086141.txt : 20160304 0001144204-16-086141.hdr.sgml : 20160304 20160304163059 ACCESSION NUMBER: 0001144204-16-086141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160302 FILED AS OF DATE: 20160304 DATE AS OF CHANGE: 20160304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DERMA SCIENCES, INC. CENTRAL INDEX KEY: 0000892160 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232328753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DERMA SCIENCES INC DATE OF NAME CHANGE: 19940513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COLE ROBERT C CENTRAL INDEX KEY: 0001218007 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13070 FILM NUMBER: 161485640 MAIL ADDRESS: STREET 1: 1248 YELLOW SPRINGS RD CITY: CHESTER SPRINGS STATE: PA ZIP: 19425 4 1 v433422_4.xml FORM 4 X0306 4 2016-03-02 0 0000892160 DERMA SCIENCES, INC. DSCI 0001218007 COLE ROBERT C 1248 YELLOW SPRINGS RD CHESTER SPRINGS PA 19425 0 1 0 0 See Remarks Common Stock 2016-03-02 4 A 0 3100 0 A 72472 D Common Stock 2016-03-02 4 F 0 1136 3.30 D 71336 D Stock Option (right to buy) 8.83 2016-03-02 4 A 0 10400 0 A 2016-03-02 2025-02-12 Common Stock 10400 10400 D Stock Option (right to buy) 3.30 2016-03-02 4 A 0 12000 0 A 2016-03-02 2026-03-02 Common Stock 12000 12000 D The shares of common stock reported herein represent restricted stock units issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on February 12, 2015, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2015, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2015 were met, resulting in the vesting of 3,100 restricted stock units. Shares withheld in connection with the vesting of 3,100 restricted stock units, previously granted pursuant to the issuer's equity incentive plan, at a closing price of $3.30, as reported herein. The options reported herein were issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on February 12, 2015, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2015, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2015 were met, resulting in the vesting of 10,400 options. The options, granted pursuant to the issuer's equity incentive plan, vested as to 25% on the grant date and will vest as to an additional 25% on March 2 of 2017, 2018 and 2019. Group President, Traditional Wound Care & Corporate Accounts /s/ Robert C. Cole 2016-03-04